Professor Bernard Mach
MD, PhD |
 |
Dr. Bernard Mach is the Founder of
Novimmune, of which he is Chairman. Former
professor and director of the Department of Genetics
and Microbiology, Faculty of Medicine, University of
Geneva, Dr. Mach is the inventor of cDNA cloning
and is specialized in the molecular biology of
immune response genes. He was co-founder and
member of the SAB of Biogen (1978-1992) and since 1994, Dr. Mach has been
Chairman of the Lombard Odier Immunology Fund
Scientific Advisory Board; Member of
Aravis Venture Partners; Member of the Board of
Directors of Serono and Vice-Chairman of the Board
of Lonza as well as Scientific Advisor to various
institutes and companies. From 1974 to 1984, he was a Member of the
Swiss Science Council and is presently a special
member of the Swiss Academy of Medical Sciences and of the French Academy of Sciences.
|
